Non-profit Bill & Melinda Gates Medical Research Institute (MRI) has officially been launched, creating a new vision for drug development with a clear focus on the millions of people that die annually from contracting malaria, tuberculosis and diarrheal diseases.
A new blood test for pregnant women detects with 75-80% accuracy whether their pregnancies will end in premature birth. The technique can also be used to estimate a fetus’ gestational age — or the mother’s due date — as reliably as and less expensively than ultrasound.
A research team has identified the essential role of a structural protein in the silencing of the inactive X chromosome, a process that prevents both copies of the same gene from being expressed in female mammals, which carry two copies of the X chromosome.
Researchers have discovered that tumour cells reprogram metabolic pathways to gain control over a type of immune cell that allows cancer growth.
Scientists now have easy access to the full power of CRISPR, without any learning curve, thanks to Synthego’s Engineered Cells Portfolio.
Researchers have synthesized the first artificial human prion, a dramatic development in efforts to combat a devastating form of brain disease that has so far eluded treatment and a cure.
The study of viral ecology is taking major leaps forward with the use of long-read sequencing and viral metagenomics. On this webinar we discuss how MinION technology is bringing scientists closer to high-throughput single-virus genomics from environmental samples.
The genomes of more than 3000 of these bacteria have been mapped by scientists in order to better understand diseases and the mechanisms of antibiotic resistance.
A new study provides a unique look at a novel strategy — clinical trials in a dish — that bridges preclinical testing and clinical trials.